Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

PREVYMIS

×

Overview

What is PREVYMIS?

PREVYMIS contains letermovir, an inhibitor of the CMV DNA terminase complex, and is administered orally or by intravenous infusion.

PREVYMIS is available as 240 mg and 480 mg tablets. PREVYMIS tablets contain either 240 mg or 480 mg of letermovir and the following inactive ingredients: colloidal silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, povidone 25, and film-coated with a coating material containing the following inactive ingredients: hypromellose 2910, iron oxide red (only for 480 mg tablets), iron oxide yellow, lactose monohydrate, titanium dioxide, and triacetin, Carnauba wax is added as a polishing agent.

PREVYMIS is also available as 240 mg and 480 mg injection for intravenous infusion. PREVYMIS injection is a clear, preservative-free sterile solution in single-dose vials of either 240 mg or 480 mg per vial. Each 1 mL of solution contains 20 mg letermovir, hydroxypropyl betadex (150 mg), sodium chloride (3.1 mg), sodium hydroxide (1.2 mg), and Water for Injection, USP. The amount of sodium hydroxide may be adjusted to achieve a pH of approximately 7.5.

Letermovir has a molecular formula of CHFNO and a molecular weight of 572.55. The chemical name for letermovir is (4)-2-{8-Fluoro-2-[4-(3- methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5- (trifluoromethyl)phenyl]-3,4-dihydroquinazolin-4-yl}acetic acid. Letermovir is very slightly soluble in water.

The chemical structure of letermovir is:



What does PREVYMIS look like?



What are the available doses of PREVYMIS?

What should I talk to my health care provider before I take PREVYMIS?

How should I use PREVYMIS?

PREVYMIS™ is indicated for prophylaxis of cytomegalovirus (CMV) infection and disease in adult CMV-seropositive recipients [R+] of an allogeneic hematopoietic stem cell transplant (HSCT).

PREVYMIS™ Tablets

PREVYMIS™ Injection


What interacts with PREVYMIS?

Sorry No Records found


What are the warnings of PREVYMIS?

Sorry No Records found


What are the precautions of PREVYMIS?

Sorry No Records found


What are the side effects of PREVYMIS?

Sorry No records found


What should I look out for while using PREVYMIS?

Pimozide. ()

Ergot Alkaloids. ()

Pitavastatin and simvastatin when co-administered with cyclosporine. ()


What might happen if I take too much PREVYMIS?

There is no specific antidote for overdose with PREVYMIS. In case of overdose, it is recommended that the patient be monitored for adverse reactions and appropriate symptomatic treatment be instituted.

It is unknown whether dialysis will result in meaningful removal of PREVYMIS from systemic circulation.


How should I store and handle PREVYMIS?

Store at room temperature; avoid excessive heat. Protect from light. Keep bottle tightly closed.Hydrocodone Bitartrate and Acetaminophen Tablet USP, 5 mg/325 mg35356-796-30 Bottles of 3035356-796-40 Bottles of 4035356-796-50 Bottles of 5035356-796-60 Bottles of 6035356-796-90 Bottles of 9035356-796-01 Bottles of 120 is available as white to off-white, capsule shaped tablets, debossed with “U02” on one side and break-line on the other side. Each tablet contains 7.5 mg hydrocodone bitartrate and 325 mg acetaminophen. 35356-797-30 Bottles of 3035356-797-40 Bottles of 4035356-797-60 Bottles of 6035356-797-90 Bottles of 9035356-797-01 Bottles of 120 is available as white to off-white, oval shaped tablets, debossed with “U03” on one side and break-line on the other side. Each tablet contains 10 mg hydrocodone bitartrate and 325 mg acetaminophen.35356-795-30 Bottles of 3035356-795-60 Bottles of 6035356-795-90 Bottles of 9035356-795-01 Bottles of 120 Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure. Keep this and all medication out of the reach of children. A Schedule C-III controlled drug substance. Manufactured by: Dayton, NJ 08810 Manufactured for: Dayton, NJ 08810 Revised: 07/2011Hydrocodone Bitartrate and Acetaminophen Tablet USP, 5 mg/325 mg35356-796-30 Bottles of 3035356-796-40 Bottles of 4035356-796-50 Bottles of 5035356-796-60 Bottles of 6035356-796-90 Bottles of 9035356-796-01 Bottles of 120 is available as white to off-white, capsule shaped tablets, debossed with “U02” on one side and break-line on the other side. Each tablet contains 7.5 mg hydrocodone bitartrate and 325 mg acetaminophen. 35356-797-30 Bottles of 3035356-797-40 Bottles of 4035356-797-60 Bottles of 6035356-797-90 Bottles of 9035356-797-01 Bottles of 120 is available as white to off-white, oval shaped tablets, debossed with “U03” on one side and break-line on the other side. Each tablet contains 10 mg hydrocodone bitartrate and 325 mg acetaminophen.35356-795-30 Bottles of 3035356-795-60 Bottles of 6035356-795-90 Bottles of 9035356-795-01 Bottles of 120 Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure. Keep this and all medication out of the reach of children. A Schedule C-III controlled drug substance. Manufactured by: Dayton, NJ 08810 Manufactured for: Dayton, NJ 08810 Revised: 07/2011Hydrocodone Bitartrate and Acetaminophen Tablet USP, 5 mg/325 mg35356-796-30 Bottles of 3035356-796-40 Bottles of 4035356-796-50 Bottles of 5035356-796-60 Bottles of 6035356-796-90 Bottles of 9035356-796-01 Bottles of 120 is available as white to off-white, capsule shaped tablets, debossed with “U02” on one side and break-line on the other side. Each tablet contains 7.5 mg hydrocodone bitartrate and 325 mg acetaminophen. 35356-797-30 Bottles of 3035356-797-40 Bottles of 4035356-797-60 Bottles of 6035356-797-90 Bottles of 9035356-797-01 Bottles of 120 is available as white to off-white, oval shaped tablets, debossed with “U03” on one side and break-line on the other side. Each tablet contains 10 mg hydrocodone bitartrate and 325 mg acetaminophen.35356-795-30 Bottles of 3035356-795-60 Bottles of 6035356-795-90 Bottles of 9035356-795-01 Bottles of 120 Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure. Keep this and all medication out of the reach of children. A Schedule C-III controlled drug substance. Manufactured by: Dayton, NJ 08810 Manufactured for: Dayton, NJ 08810 Revised: 07/2011Hydrocodone Bitartrate and Acetaminophen Tablet USP, 5 mg/325 mg35356-796-30 Bottles of 3035356-796-40 Bottles of 4035356-796-50 Bottles of 5035356-796-60 Bottles of 6035356-796-90 Bottles of 9035356-796-01 Bottles of 120 is available as white to off-white, capsule shaped tablets, debossed with “U02” on one side and break-line on the other side. Each tablet contains 7.5 mg hydrocodone bitartrate and 325 mg acetaminophen. 35356-797-30 Bottles of 3035356-797-40 Bottles of 4035356-797-60 Bottles of 6035356-797-90 Bottles of 9035356-797-01 Bottles of 120 is available as white to off-white, oval shaped tablets, debossed with “U03” on one side and break-line on the other side. Each tablet contains 10 mg hydrocodone bitartrate and 325 mg acetaminophen.35356-795-30 Bottles of 3035356-795-60 Bottles of 6035356-795-90 Bottles of 9035356-795-01 Bottles of 120 Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure. Keep this and all medication out of the reach of children. A Schedule C-III controlled drug substance. Manufactured by: Dayton, NJ 08810 Manufactured for: Dayton, NJ 08810 Revised: 07/2011Hydrocodone Bitartrate and Acetaminophen Tablet USP, 5 mg/325 mg35356-796-30 Bottles of 3035356-796-40 Bottles of 4035356-796-50 Bottles of 5035356-796-60 Bottles of 6035356-796-90 Bottles of 9035356-796-01 Bottles of 120 is available as white to off-white, capsule shaped tablets, debossed with “U02” on one side and break-line on the other side. Each tablet contains 7.5 mg hydrocodone bitartrate and 325 mg acetaminophen. 35356-797-30 Bottles of 3035356-797-40 Bottles of 4035356-797-60 Bottles of 6035356-797-90 Bottles of 9035356-797-01 Bottles of 120 is available as white to off-white, oval shaped tablets, debossed with “U03” on one side and break-line on the other side. Each tablet contains 10 mg hydrocodone bitartrate and 325 mg acetaminophen.35356-795-30 Bottles of 3035356-795-60 Bottles of 6035356-795-90 Bottles of 9035356-795-01 Bottles of 120 Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure. Keep this and all medication out of the reach of children. A Schedule C-III controlled drug substance. Manufactured by: Dayton, NJ 08810 Manufactured for: Dayton, NJ 08810 Revised: 07/2011Hydrocodone Bitartrate and Acetaminophen Tablet USP, 5 mg/325 mg35356-796-30 Bottles of 3035356-796-40 Bottles of 4035356-796-50 Bottles of 5035356-796-60 Bottles of 6035356-796-90 Bottles of 9035356-796-01 Bottles of 120 is available as white to off-white, capsule shaped tablets, debossed with “U02” on one side and break-line on the other side. Each tablet contains 7.5 mg hydrocodone bitartrate and 325 mg acetaminophen. 35356-797-30 Bottles of 3035356-797-40 Bottles of 4035356-797-60 Bottles of 6035356-797-90 Bottles of 9035356-797-01 Bottles of 120 is available as white to off-white, oval shaped tablets, debossed with “U03” on one side and break-line on the other side. Each tablet contains 10 mg hydrocodone bitartrate and 325 mg acetaminophen.35356-795-30 Bottles of 3035356-795-60 Bottles of 6035356-795-90 Bottles of 9035356-795-01 Bottles of 120 Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure. Keep this and all medication out of the reach of children. A Schedule C-III controlled drug substance. Manufactured by: Dayton, NJ 08810 Manufactured for: Dayton, NJ 08810 Revised: 07/2011Hydrocodone Bitartrate and Acetaminophen Tablet USP, 5 mg/325 mg35356-796-30 Bottles of 3035356-796-40 Bottles of 4035356-796-50 Bottles of 5035356-796-60 Bottles of 6035356-796-90 Bottles of 9035356-796-01 Bottles of 120 is available as white to off-white, capsule shaped tablets, debossed with “U02” on one side and break-line on the other side. Each tablet contains 7.5 mg hydrocodone bitartrate and 325 mg acetaminophen. 35356-797-30 Bottles of 3035356-797-40 Bottles of 4035356-797-60 Bottles of 6035356-797-90 Bottles of 9035356-797-01 Bottles of 120 is available as white to off-white, oval shaped tablets, debossed with “U03” on one side and break-line on the other side. Each tablet contains 10 mg hydrocodone bitartrate and 325 mg acetaminophen.35356-795-30 Bottles of 3035356-795-60 Bottles of 6035356-795-90 Bottles of 9035356-795-01 Bottles of 120 Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure. Keep this and all medication out of the reach of children. A Schedule C-III controlled drug substance. Manufactured by: Dayton, NJ 08810 Manufactured for: Dayton, NJ 08810 Revised: 07/2011Hydrocodone Bitartrate and Acetaminophen Tablet USP, 5 mg/325 mg35356-796-30 Bottles of 3035356-796-40 Bottles of 4035356-796-50 Bottles of 5035356-796-60 Bottles of 6035356-796-90 Bottles of 9035356-796-01 Bottles of 120 is available as white to off-white, capsule shaped tablets, debossed with “U02” on one side and break-line on the other side. Each tablet contains 7.5 mg hydrocodone bitartrate and 325 mg acetaminophen. 35356-797-30 Bottles of 3035356-797-40 Bottles of 4035356-797-60 Bottles of 6035356-797-90 Bottles of 9035356-797-01 Bottles of 120 is available as white to off-white, oval shaped tablets, debossed with “U03” on one side and break-line on the other side. Each tablet contains 10 mg hydrocodone bitartrate and 325 mg acetaminophen.35356-795-30 Bottles of 3035356-795-60 Bottles of 6035356-795-90 Bottles of 9035356-795-01 Bottles of 120 Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure. Keep this and all medication out of the reach of children. A Schedule C-III controlled drug substance. Manufactured by: Dayton, NJ 08810 Manufactured for: Dayton, NJ 08810 Revised: 07/2011Hydrocodone Bitartrate and Acetaminophen Tablet USP, 5 mg/325 mg35356-796-30 Bottles of 3035356-796-40 Bottles of 4035356-796-50 Bottles of 5035356-796-60 Bottles of 6035356-796-90 Bottles of 9035356-796-01 Bottles of 120 is available as white to off-white, capsule shaped tablets, debossed with “U02” on one side and break-line on the other side. Each tablet contains 7.5 mg hydrocodone bitartrate and 325 mg acetaminophen. 35356-797-30 Bottles of 3035356-797-40 Bottles of 4035356-797-60 Bottles of 6035356-797-90 Bottles of 9035356-797-01 Bottles of 120 is available as white to off-white, oval shaped tablets, debossed with “U03” on one side and break-line on the other side. Each tablet contains 10 mg hydrocodone bitartrate and 325 mg acetaminophen.35356-795-30 Bottles of 3035356-795-60 Bottles of 6035356-795-90 Bottles of 9035356-795-01 Bottles of 120 Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure. Keep this and all medication out of the reach of children. A Schedule C-III controlled drug substance. Manufactured by: Dayton, NJ 08810 Manufactured for: Dayton, NJ 08810 Revised: 07/2011Hydrocodone Bitartrate and Acetaminophen Tablet USP, 5 mg/325 mg35356-796-30 Bottles of 3035356-796-40 Bottles of 4035356-796-50 Bottles of 5035356-796-60 Bottles of 6035356-796-90 Bottles of 9035356-796-01 Bottles of 120 is available as white to off-white, capsule shaped tablets, debossed with “U02” on one side and break-line on the other side. Each tablet contains 7.5 mg hydrocodone bitartrate and 325 mg acetaminophen. 35356-797-30 Bottles of 3035356-797-40 Bottles of 4035356-797-60 Bottles of 6035356-797-90 Bottles of 9035356-797-01 Bottles of 120 is available as white to off-white, oval shaped tablets, debossed with “U03” on one side and break-line on the other side. Each tablet contains 10 mg hydrocodone bitartrate and 325 mg acetaminophen.35356-795-30 Bottles of 3035356-795-60 Bottles of 6035356-795-90 Bottles of 9035356-795-01 Bottles of 120 Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure. Keep this and all medication out of the reach of children. A Schedule C-III controlled drug substance. Manufactured by: Dayton, NJ 08810 Manufactured for: Dayton, NJ 08810 Revised: 07/2011Hydrocodone Bitartrate and Acetaminophen Tablet USP, 5 mg/325 mg35356-796-30 Bottles of 3035356-796-40 Bottles of 4035356-796-50 Bottles of 5035356-796-60 Bottles of 6035356-796-90 Bottles of 9035356-796-01 Bottles of 120 is available as white to off-white, capsule shaped tablets, debossed with “U02” on one side and break-line on the other side. Each tablet contains 7.5 mg hydrocodone bitartrate and 325 mg acetaminophen. 35356-797-30 Bottles of 3035356-797-40 Bottles of 4035356-797-60 Bottles of 6035356-797-90 Bottles of 9035356-797-01 Bottles of 120 is available as white to off-white, oval shaped tablets, debossed with “U03” on one side and break-line on the other side. Each tablet contains 10 mg hydrocodone bitartrate and 325 mg acetaminophen.35356-795-30 Bottles of 3035356-795-60 Bottles of 6035356-795-90 Bottles of 9035356-795-01 Bottles of 120 Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure. Keep this and all medication out of the reach of children. A Schedule C-III controlled drug substance. Manufactured by: Dayton, NJ 08810 Manufactured for: Dayton, NJ 08810 Revised: 07/2011Hydrocodone Bitartrate and Acetaminophen Tablet USP, 5 mg/325 mg35356-796-30 Bottles of 3035356-796-40 Bottles of 4035356-796-50 Bottles of 5035356-796-60 Bottles of 6035356-796-90 Bottles of 9035356-796-01 Bottles of 120 is available as white to off-white, capsule shaped tablets, debossed with “U02” on one side and break-line on the other side. Each tablet contains 7.5 mg hydrocodone bitartrate and 325 mg acetaminophen. 35356-797-30 Bottles of 3035356-797-40 Bottles of 4035356-797-60 Bottles of 6035356-797-90 Bottles of 9035356-797-01 Bottles of 120 is available as white to off-white, oval shaped tablets, debossed with “U03” on one side and break-line on the other side. Each tablet contains 10 mg hydrocodone bitartrate and 325 mg acetaminophen.35356-795-30 Bottles of 3035356-795-60 Bottles of 6035356-795-90 Bottles of 9035356-795-01 Bottles of 120 Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure. Keep this and all medication out of the reach of children. A Schedule C-III controlled drug substance. Manufactured by: Dayton, NJ 08810 Manufactured for: Dayton, NJ 08810 Revised: 07/2011Hydrocodone Bitartrate and Acetaminophen Tablet USP, 5 mg/325 mg35356-796-30 Bottles of 3035356-796-40 Bottles of 4035356-796-50 Bottles of 5035356-796-60 Bottles of 6035356-796-90 Bottles of 9035356-796-01 Bottles of 120 is available as white to off-white, capsule shaped tablets, debossed with “U02” on one side and break-line on the other side. Each tablet contains 7.5 mg hydrocodone bitartrate and 325 mg acetaminophen. 35356-797-30 Bottles of 3035356-797-40 Bottles of 4035356-797-60 Bottles of 6035356-797-90 Bottles of 9035356-797-01 Bottles of 120 is available as white to off-white, oval shaped tablets, debossed with “U03” on one side and break-line on the other side. Each tablet contains 10 mg hydrocodone bitartrate and 325 mg acetaminophen.35356-795-30 Bottles of 3035356-795-60 Bottles of 6035356-795-90 Bottles of 9035356-795-01 Bottles of 120 Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure. Keep this and all medication out of the reach of children. A Schedule C-III controlled drug substance. Manufactured by: Dayton, NJ 08810 Manufactured for: Dayton, NJ 08810 Revised: 07/2011Hydrocodone Bitartrate and Acetaminophen Tablet USP, 5 mg/325 mg35356-796-30 Bottles of 3035356-796-40 Bottles of 4035356-796-50 Bottles of 5035356-796-60 Bottles of 6035356-796-90 Bottles of 9035356-796-01 Bottles of 120 is available as white to off-white, capsule shaped tablets, debossed with “U02” on one side and break-line on the other side. Each tablet contains 7.5 mg hydrocodone bitartrate and 325 mg acetaminophen. 35356-797-30 Bottles of 3035356-797-40 Bottles of 4035356-797-60 Bottles of 6035356-797-90 Bottles of 9035356-797-01 Bottles of 120 is available as white to off-white, oval shaped tablets, debossed with “U03” on one side and break-line on the other side. Each tablet contains 10 mg hydrocodone bitartrate and 325 mg acetaminophen.35356-795-30 Bottles of 3035356-795-60 Bottles of 6035356-795-90 Bottles of 9035356-795-01 Bottles of 120 Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure. Keep this and all medication out of the reach of children. A Schedule C-III controlled drug substance. Manufactured by: Dayton, NJ 08810 Manufactured for: Dayton, NJ 08810 Revised: 07/2011Hydrocodone Bitartrate and Acetaminophen Tablet USP, 5 mg/325 mg35356-796-30 Bottles of 3035356-796-40 Bottles of 4035356-796-50 Bottles of 5035356-796-60 Bottles of 6035356-796-90 Bottles of 9035356-796-01 Bottles of 120 is available as white to off-white, capsule shaped tablets, debossed with “U02” on one side and break-line on the other side. Each tablet contains 7.5 mg hydrocodone bitartrate and 325 mg acetaminophen. 35356-797-30 Bottles of 3035356-797-40 Bottles of 4035356-797-60 Bottles of 6035356-797-90 Bottles of 9035356-797-01 Bottles of 120 is available as white to off-white, oval shaped tablets, debossed with “U03” on one side and break-line on the other side. Each tablet contains 10 mg hydrocodone bitartrate and 325 mg acetaminophen.35356-795-30 Bottles of 3035356-795-60 Bottles of 6035356-795-90 Bottles of 9035356-795-01 Bottles of 120 Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure. Keep this and all medication out of the reach of children. A Schedule C-III controlled drug substance. Manufactured by: Dayton, NJ 08810 Manufactured for: Dayton, NJ 08810 Revised: 07/2011


×

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

PREVYMIS is an antiviral drug against CMV .

Non-Clinical Toxicology
Pimozide. ()

Ergot Alkaloids. ()

Pitavastatin and simvastatin when co-administered with cyclosporine. ()

The concomitant use of PREVYMIS and certain drugs may result in potentially significant drug interactions, some of which may lead to adverse reactions (PREVYMIS or concomitant drugs) or reduced therapeutic effect of PREVYMIS or the concomitant drug

See for steps to prevent or manage these possible or known significant drug interactions, including dosing recommendations. Consider the potential for drug interactions prior to and during PREVYMIS therapy; review concomitant medications during PREVYMIS therapy; and monitor for adverse reactions associated with PREVYMIS and concomitant medications.

×

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

×

Review

Rate this treatment and share your opinion


Learn about User Reviews

Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

Effectiveness (required)

This medication has worked for me.




Ease of Use (required)

This medication has been easy for me to use.




Satisfaction (required)

Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
×

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
×

Tips

Tips

×

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).